Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol DHFR contributors: mct - updated : 18-03-2011
HGNC name dihydrofolate reductase
HGNC id 2861
Corresponding disease
DHFRD dehydrofolate deficiency
Location 5q14.1      Physical location : 79.922.044 - 79.950.800
EC.number 1.5.1.3
DNA
TYPE functioning gene
STRUCTURE 28.75 kb     6 Exon(s)
10 Kb 5' upstream gene genomic sequence study
regulatory sequence
text structure cis-acting regulatory element in the protein-coding region , mediating RNA-protein interactions
MAPPING cloned Y linked Y status confirmed
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
6 - 3932 - 187 - 2004 14664697
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart   highly
Digestiveintestinelarge intestinecolon highly
Lymphoid/Immunelymph node   highly
 thymus   highly
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period
cell cycle     cell cycle, S
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
HOMOLOGY
interspecies homolog to Drosophila Dhfr
homolog to C.elegans C36B1.7
ortholog to murine Dhfr
Homologene
FAMILY dihydrofolate reductase family
CATEGORY enzyme
SUBCELLULAR LOCALIZATION     intracellular
intracellular,cytoplasm
basic FUNCTION
  • converting dihydrofolate into tetrahydrofolate, a methyl group shuttle required for the de novo synthesis of purines, thymidylic acid and certain amino acids
  • catalyzes the NADPH-dependent reduction of dihydrofolate to tetrahydrofolate, an essential step in the synthesis of precursors of DNA, including glycine and purines, and the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate
  • modulator of beta-catenin and GSK3 signaling
  • necessary for maintaining sufficient cerebrospinal fluid and red blood cells folate levels, even in the presence of adequate nutritional folate supply and normal plasma folate
  • plays a key role in maintaining intracellular folate homeostasis and is an important target for cytostatic drugs
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS immunity/defense
    PATHWAY
    metabolism nucleic , aminoacid , purine/pyrimidine , vitamin
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule cofactor, nucleotide,
    NADP
    protein interacting with MDM2 (ability of MDM2 to inhibit DHFR activity depends upon an intact MDM2 RING finger)
    cell & other
    REGULATION
    activated by upregulated MYC target gene
    repressed by HOA repressed the expression of dihydrofolate reductase (DHFR), the enzyme responsible for tetrahydrofolate (THF) synthesis
    ASSOCIATED DISORDERS
    corresponding disease(s) DHFRD
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional   deletion    
    polymorphism in intron 1 significantly more frequent in mother with foetus spina bifida
    constitutional   deletion    
    associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate
    Susceptibility
  • to spina bifida
  • to intracranial aneurysms
  • Variant & Polymorphism other
  • polymorphisms are possible risk factors for the formation of intracranial aneurysms
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    critical target in cancer chemotherapy
    ANIMAL & CELL MODELS